ciprofloxacin has been researched along with Hyperoxia in 1 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Hyperoxia: An abnormal increase in the amount of oxygen in the tissues and organs.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schwartz, FA | 1 |
| Lerche, CJ | 1 |
| Christophersen, L | 1 |
| Jensen, PØ | 1 |
| Laulund, AS | 1 |
| Woetmann, A | 1 |
| Høiby, N | 1 |
| Moser, C | 1 |
1 other study available for ciprofloxacin and Hyperoxia
| Article | Year |
|---|---|
Distinct contribution of hyperbaric oxygen therapy to human neutrophil function and antibiotic efficacy against Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Combined Modality Therapy; Humans; Hyperbaric Oxygenation; Hyp | 2021 |